Skip to Main Content
Wyss Institute
Menu
Search Site
How We Work
Technologies
Collaboration
Team
News
Search
Search results
4 Results for 'Novartis'
Technologies
(1)
Collaborations
(0)
Team
(0)
News
(3)
Events
(0)
Multimedia
(0)
Publications
(0)
Jobs
(0)
Technologies
1
Implantable Cancer Vaccine
The implantable cancer vaccine is an aspirin-sized disc that is implanted under the skin and serves as an artificial lymph node, recruiting and training a patient's own immune cells to find and kill their cancer cells. It was validated in a Phase I clinical trial at the Wyss Institute, and is currently being developed by Novartis to treat melanoma.
News
3
Research Spotlights
Wyss technology featured in New Museum art exhibit
September 21, 2021
Research Spotlights
Harnessing Nature to Beat Cancer
February 28, 2019
Translation News
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
March 20, 2018
Close search results
How We Work
Technologies
Collaboration
Team
News
Contact
Careers
Events
Multimedia
Resources
Publications
Impact Report
Wiki Login
Close menu
Implantable Cancer Vaccine
